Dr. Craig McDonald
Claim this profileUniversity of California, Davis
Studies Muscular Dystrophy
Studies Duchenne Muscular Dystrophy
8 reported clinical trials
8 drugs studied
Area of expertise
1Muscular Dystrophy
DMD
Duchenne mutation positive
exon 44 positive
2Duchenne Muscular Dystrophy
DMD
Duchenne mutation positive
exon 44 positive
Affiliated Hospitals
Clinical Trials Craig McDonald is currently running
Gene Therapy
for Duchenne Muscular Dystrophy
The study will evaluate the safety and efficacy of delandistrogene moxeparvovec gene transfer therapy in non-ambulatory and ambulatory males with DMD. This is a randomized, double-blind, placebo-controlled 2-part study. Participants will be in the study for approximately 128 weeks. All participants will have the opportunity to receive intravenous (IV) delandistrogene moxeparvovec in either Part 1 or Part 2.
Recruiting1 award Phase 35 criteria
Cell Therapy
for Duchenne Muscular Dystrophy
This trial tests a cell therapy called CAP-1002 in boys and young men with Duchenne muscular dystrophy. The therapy involves giving special cells through an IV to help improve muscle function. The goal is to see if this treatment can repair or regenerate damaged muscles.
Recruiting1 award Phase 31 criteria
More about Craig McDonald
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Craig McDonald has experience with
- Placebo
- Corticosteroids
- Pamrevlumab
- SRP-9001 (Delandistrogene Moxeparvovec)
- Vamorolone
- CAP-1002
Breakdown of trials Craig McDonald has run
Muscular Dystrophy
Duchenne Muscular Dystrophy
Muscular Disorders
Genetic Diseases
Neuromuscular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Craig McDonald specialize in?
Craig McDonald focuses on Muscular Dystrophy and Duchenne Muscular Dystrophy. In particular, much of their work with Muscular Dystrophy has involved DMD patients, or patients who are Duchenne mutation positive.
Is Craig McDonald currently recruiting for clinical trials?
Yes, Craig McDonald is currently recruiting for 2 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Craig McDonald has studied deeply?
Yes, Craig McDonald has studied treatments such as Placebo, Corticosteroids, Pamrevlumab.
What is the best way to schedule an appointment with Craig McDonald?
Apply for one of the trials that Craig McDonald is conducting.
What is the office address of Craig McDonald?
The office of Craig McDonald is located at: University of California, Davis, Sacramento, California 95817 United States. This is the address for their practice at the University of California, Davis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.